Federal Register Watch: April 29, 2026 — DEA Schedules FDA-Approved Cannabis to III, Sets New Marijuana Hearing
DEA reschedules FDA-approved cannabis products to Schedule III and sets a new hearing on broader marijuana rescheduling; HUD reopens Equal Access; FERC sets pipeline index; ITA hits Indian solar; CBP…
